Studies on the Biochemical Sequelae of Therapy in Thy-Acute Lymphoblastic Leukaemia with the Adenosine Deaminase Inhibitor 2’Deoxycoformycin
- 1 September 1981
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 49 (1), 1-9
- https://doi.org/10.1111/j.1365-2141.1981.tb07190.x
Abstract
Summary. In four patients with Thy-acute lymphoblastic leukaemia changes in blast cell deoxynucleoside triphosphate concentrations and, in three, changes in blast cell S-adenosyl homocysteine hydrolase activity were measured during treatment with 2’deoxycoformycin, a potent inhibitor of adenosine deaminase. These studies were aimed at identifying the molecular basis of cell killing by this drug. In three patients an increase in blast deoxyadenosine triphosphate (dATP) concentration occurred which was found to be temporally related to cell killing and was accompanied by decreased concentrations of the other three deoxyribonucleoside triphosphates. In the one patient with Thy-ALL who responded poorly to treatment, the increase in dATP concentration was delayed and was not accompanied by a fall in the concentrations of the other deoxyribonucleoside triphosphates. Progressive inactivation of blast cell S-adenosyl homocysteine hydrolase was found to occur in the three patients tested but was maximal only after a substantial reduction of peripheral blast cell count. These results show that 2’deoxycoformycin has a potent cytoreductive effect in Thy-ALL and suggest that the molecular basis of this toxicity is related both to the intracellular accumulation of dATP with inhibition of ribonucleotide reductase. Inactivation of S-adenosyl homocysteine hydrolase may be of importance as an additional mechanism.This publication has 31 references indexed in Scilit:
- REMISSION INDUCTION WITH ADENOSINE-DEAMINASE INHIBITOR 2'-DEOXYCOFORMYCIN IN THY-LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1980
- Reduction of RibonucleotidesAnnual Review of Biochemistry, 1979
- Correlation of adenosine deaminase activity with cell surface markers in acute lymphoblastic leukemia.JCI Insight, 1978
- Role of S-adenosylhomocysteine in adenosine-mediated toxicity in cultured mouse T lymphoma cellsCell, 1977
- Tight-binding inhibitors—IV. Inhibition of adenosine deaminases by various inhibitorsBiochemical Pharmacology, 1977
- A sensitive isotopic assay method for hydrolaseBiochimica et Biophysica Acta (BBA) - Enzymology, 1976
- Adenosine deaminase activity in chronic lymphocytic leukemia. Relationship to B- and T-cell subpopulations.JCI Insight, 1976
- Micromethod for quantitation of adenosine deaminase activity in cells from human peripheral bloodBiochemical Medicine, 1975
- Deoxyribonucleoside Triphosphates in Human Cells: Changes in Disease and Following Exposure to DrugsEuropean Journal of Clinical Investigation, 1975
- ADENOSINE-DEAMINASE DEFICIENCY IN TWO PATIENTS WITH SEVERELY IMPAIRED CELLULAR IMMUNITYThe Lancet, 1972